3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Neoplasms
14
Lung Neoplasms
10
Colonic Neoplasms
10
Breast Neoplasms
9
Brain Neoplasms
6
Prostatic Neoplasms
4
Emergence Delirium
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Respiratory Aspiration
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Neoplastic Cells, Circulating
3
Hypoxia
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Agnosia
3
Supratentorial Neoplasms
2
Postoperative Complications
2
Patient Satisfaction
2
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Melanoma
2
Liver Neoplasms
2
Leukemia
2
Delirium
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Tuberculosis, Pulmonary
1
Interventions
Exercise
6
Counseling
6
Nutrition Assessment
5
Methods
3
Diet Therapy
3
Caloric Restriction
3
Tirzepatide
2
Resistance Training
2
Naltrexone
2
Metformin
2
Megestrol Acetate
2
Exenatide
2
Educational Status
2
Early Intervention, Educational
2
Diet
2
Cognitive Behavioral Therapy
2
Bupropion
2
sultamicillin
1
semaglutide
1
licogliflozin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Ursodeoxycholic Acid
1
Trehalase
1
Tobacco Use Cessation Devices
1
Tablets
1
Surveys and Questionnaires
1
Sugars
1
Sucrose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Overweight
×
Propofol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled